Aptus Capital Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Aptus Capital Advisors's ELV Position: Q3 2026 in Review
Aptus Capital Advisors increased its Elevance Health (ELV) stake by 1.5% in Q3 2026, buying an estimated $138K and bringing the position to 23,165 shares worth $9.01M. The position accounts for 0.06% of the portfolio, ranked #260.
Aptus Capital Advisors first reported a position in ELV in Q1 2021 and has held it in 23 quarters since. The position peaked at $22.1M in Q2 2025. 1,626 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Aptus Capital Advisors held 23,165 shares of Elevance Health worth $9.01M as of Q3 2026.
- Aptus Capital Advisors bought 347 Elevance Health shares in Q3 2026, an estimated $138K.
- Elevance Health made up 0.06% of Aptus Capital Advisors's portfolio in Q3 2026, its #260 holding.
- Aptus Capital Advisors first reported a position in Elevance Health in Q1 2021 and has held it in 23 quarters since.
- Aptus Capital Advisors's Elevance Health position peaked at $22.1M in Q2 2025.
- 1,626 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Aptus Capital Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.